Infectious disorders drug targets
Phenotypic and Genotypic Characterization of ESBL- and Carbapenemase-producing Escherichia coli Isolates in Irritable Bowel Syndrome (IBS) Patients.
Anis Ramezani, Mohammad Yazdanmanesh, Hamid Heidari, Arezo Khadiv, Fateme Yazdani, Hamidreza Houri, Morteza Karami-Zarandi, Hossein Kazemian
Published: 202610.2174/0118715265415259251104122457
Abstract
INTRODUCTION: The prevalence of irritable bowel syndrome (IBS) is estimated to range from 10% to 20%. The symptoms of IBS have been associated with an increased presence of Escherichia coli bacteria in the bowel. Treatment is often complicated by the…
Preview only. Read the full abstract at the source